NCT01471522

N/AInterventional

Trials without FDA-defined phases, including trials of devices or behavioral interventions.

View on ClinicalTrials.gov ↗

Timeline

Start date: Jul 31, 2012
Primary completion: Jun 30, 2019
Completion date: May 30, 2023
First posted: Nov 15, 2011
Last posted: Aug 1, 2022
Enrollment: 5179
Arms / groups: 2 / —
Source: AACT · ctgov ingestion

Sponsors

New York UniversityLead sponsor
Cedars-Sinai Medical CenterCollaborator
Columbia UniversityCollaborator
Duke UniversityCollaborator
East Carolina UniversityCollaborator
Emory UniversityCollaborator
Harvard UniversityCollaborator
Harvard UniversityCollaborator
University of MontrealCollaborator
National Heart, Lung, and Blood Institute (NHLBI)Collaborator
New York UniversityCollaborator
New York UniversityStudy chair
Stanford UniversityCollaborator
Stanford UniversityOverall official - principal investigator
University of British ColumbiaCollaborator
University of Missouri, Kansas CityCollaborator
Vanderbilt UniversityCollaborator
New York UniversityOfficial
Stanford UniversityOfficial

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.